Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -7.96x is 97% above its 2-year average of -244.10x, near the high end of its 2-year range (-1402.89x–1.14x).
17.59% above its 12-month average of -9.66x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2025 (2025-09-30): -14.67x.
INTEREST COVERAGE RATIO
-7.96x
INTEREST COVERAGE RATIO AVG TTM
-9.66x
INTEREST COVERAGE RATIO AVG 3Y
-244.10x
INTEREST COVERAGE RATIO AVG 5Y
-244.10x
INTEREST COVERAGE RATIO AVG 10Y
-244.10x
INTEREST COVERAGE RATIO AVG 15Y
-175.22x
INTEREST COVERAGE RATIO AVG 20Y
-9.58x
CURRENT VS TTM AVG
+17.59%
CURRENT VS 3Y AVG
+96.74%
CURRENT VS 5Y AVG
+96.74%
CURRENT VS 10Y AVG
+96.74%
CURRENT VS 15Y AVG
+95.46%
CURRENT VS 20Y AVG
+16.95%
SECTOR MEDIAN · HEALTHCARE
-4.21x
median of 330 covered companies
CURRENT VS SECTOR MEDIAN
-89.07%
vs the sector median at left
Codexis, Inc.
Market Cap
$150.59M
Interest Coverage Ratio
-7.96x
TTM Avg
-9.66x
3Y Avg
-244.10x
5Y Avg
-244.10x
Market Cap
$153.31M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$147.02M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$153.84M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$154.57M
Interest Coverage Ratio
-29.32x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$143.81M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$142.49M
Interest Coverage Ratio
-8.06x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$142.11M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Codexis, Inc. (CDXS) | $150.59M | -7.96x | -9.66x | -244.10x | -244.10x |
| Cardiol Therapeutics Inc. (CRDL)vs › | $153.31M | N/A | N/A | N/A | N/A |
| Immuneering Corporation (IMRX)vs › | $147.02M | N/A | N/A | N/A | N/A |
| Anavex Life Sciences Corp. (AVXL)vs › | $153.84M | N/A | N/A | N/A | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $154.57M | -29.32x | N/A | N/A | N/A |
| Korsana Biosciences, Inc. (KRSA)vs › | $143.81M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMDP)vs › | $155.88M | -5.64x | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $142.49M | -8.06x | N/A | N/A | N/A |
| Alpha Cognition Inc (ACOG)vs › | $142.11M | N/A | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $138.26M | N/A | 346.24x | 936.28x | 577.46x |
Interest Coverage
-8.0x
Debt/Equity
2.20
Current Ratio
3.06
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-09-30 | -14.67x |
| 2025-03-31 | -21.75x |
| 2024-12-31 | 1.14x |
| 2024-09-30 | -3.36x |
| 2024-06-30 | -23.08x |
| 2023-06-30 | -1402.89x |
| 2011-12-31 | -16.51x |
| 2011-03-31 | -198.76x |
| 2010-12-31 | -2.06x |
| 2010-09-30 | -70.29x |
| 2010-06-30 | -4.97x |
| 2010-03-31 | -3.07x |
| 2009-12-31 | -9.32x |
| 2009-09-30 | -7.38x |
| 2009-06-30 | -6.99x |
| 2009-03-31 | -13.22x |
| 2008-12-31 | 41.98x |
| 2008-03-31 | -8.94x |
| 2007-03-31 | -170.19x |
